The biosynthesis of caprazamycins and related liponucleoside antibiotics: new insights

Bertolt Gust1, Kornelia Eitel, Xiaoyu Tang

  • 1Department of Pharmceutical Biology, Pharmaceutical Institute, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, D-72076 Tübingen, Germany. bertolt.gust@uni-tuebingen.de

Biological Chemistry
|October 30, 2012
PubMed

Insights

Caprazamycins are liponucleoside antibiotics effective against Mycobacterium species. This review compares their biosynthetic gene clusters and explores their complex structures and origins.

Area of Science:

  • Microbiology
  • Biochemistry
  • Synthetic Biology

Background:

  • Peptidoglycan biosynthesis is essential for bacterial cell walls, with MraY translocase catalyzing a key early step.
  • MraY inhibitors, including liponucleosides like caprazamycins, offer potential antibacterial strategies.
  • Caprazamycins exhibit in vitro activity against Gram-positive bacteria, notably Mycobacterium species.

Purpose of the Study:

  • To review and compare the biosynthetic gene clusters of caprazamycins, liposidomycins, and A-90289.
  • To explore the complex structures and origins of these liponucleoside antibiotics.
  • To present emerging information on liponucleoside antibiotic biosynthesis.

Main Methods:

  • Comparative analysis of recently discovered biosynthetic gene clusters.
  • Review of structural composition of caprazamycins, liposidomycins, and A-90289.
  • Integration of data from gene disruption experiments and biochemical investigations.

Main Results:

  • Caprazamycins, liposidomycins, and A-90289 share unique structural moieties derived from 5'-(β-O-aminoribosyl)-glycyluridine.
  • The N,N'-dimethyldiazepanone ring is a characteristic feature of these compounds.
  • Discovery and comparison of the corresponding biosynthetic gene clusters provide insights into their production.

Conclusions:

  • Understanding the biosynthesis of liponucleoside antibiotics is crucial for developing new antibacterial agents.
  • Comparative genomics of biosynthetic gene clusters aids in elucidating antibiotic production pathways.
  • Further research into gene disruption and biochemical studies will refine our knowledge of liponucleoside antibiotic synthesis.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Biosynthesis of Lipids01:29

Biosynthesis of Lipids

Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...
Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...